Podcasts Science Life Sciences Frankly Speaking About Family Medicine Statins and the Older Population: When Is It Beneficial and When Is It Not? - Frankly Speaking EP 96

Statins and the Older Population: When Is It Beneficial and When Is It Not? - Frankly Speaking EP 96

Published: Nov. 26, 2018, 4:15 p.m.

b'Evidence of the efficacy of statins to reduce ASCVD morbidity and mortality in individuals > 75 years who have known clinical ASCVD (secondary prevention) is well established. Primary prevention in this population has not been as clear. Join us while we discuss a recent study in the BMJ which assessed the benefits of statins for primary prevention of ASCVD morbidity and mortality in individuals > 75 years with and without DM. \\xa0 Guest: Susan Feeney, DNP, FNP-BC \\xa0 Landing Page:\\xa0 https://www.pri-med.com/online-education/Podcast/96-statin-therapy-frankly-speaking.aspx#sm.0000akbf5ldmtfh2s4u14ah34rz3b'